Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

EFFECT OF HYDROXYETHYL STARCH 200/0.5 ON VON WILLEBRAND FACTOR SERUM LEVEL AND ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)

Folia Medica Indonesiana · Vol. 51 No. 4 (2016) · pp. 221–221

DOI
10.20473/fmi.v51i4.2848
ISSN
2355-8393, 2599-056X
Published
2016-11-15
Publisher
Airlangga University
Language
en
License
creativecommons.org/licenses/by-nc-sa/4.0/

Abstract

Hydroxyethyl starch (HES) is a colloid administered frequently for intravascular volume expansion during perioperative period. Impairment of haemostasis have been reported during HES administration, but the volume of solution administered was usually higher than 20 ml.kg-1. The objective of this study was to evaluate the effect of Hydroxyethyl starch 200/0.5 dose less than 20 ml.kg-1 on von Willebrand factor serum level and activated partial thromboplastin time. A prospective, observational study was conducted to evaluate von Willebrand factor and activated partial thromboplastin time of patients receiving Hydroxyethyl starch 200/0.5. Inclusion criteria were patients undergoing elective surgery who were going to receive Hydroxyethyl starch 200/0.5 intraoperatively. Fourty six patients were divided into patients receiving crystalloid only group (n=23 patients) and hydroxyethyl starch (n=23 patients). Coagulation variables were assesed 30 minute after insicion and 60 minute after infusion of crystalloid or colloid. Measurement of von Willebrand within each group after crystalloid or HES 200 infusion showed significant decrease, from (mean±SE) 97.688±15.219 ng/ml to 31.611±10.058 ng/ml (p< 0.001) in crystalloid group and 92.884±15.208 ng/ml to 27.378±6.399 ng/ml (p<0.001) in HES 200 group. Activated partial thromboplastin time change was statistically significant (mean±SE) 31.27±1.39 to 35.61±1.62 in HES group only (p=0.007), but this change was not clinically significant. In conclusion, there was neither significant difference in von Willebrand serum level nor in activated partial thromboplastin time between the two groups. There was no coagulation influence with clinically significant effect in the use of HES 20 ml/kg BW in patients undergoing elective surgery.

Keywords

Collaboration network of the authors

40 authors · 99 co-authorship links · 35 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Airlangga
  • Lambung Mangkurat University
  • State University of Makassar
  • Universitas Kristen Immanuel
  • Universitas Gadjah Mada
  • University of Brawijaya
  • Sanata Dharma University
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Imam SusiloUniversitas Airlangga5
Ika Ayu MentariUniversitas Airlangga2
Rifda NaufalinaUniversitas Airlangga2
Selvi MegawatiUniversitas Airlangga2
Yuyun WirasasmitaTadulako University2
Suharjono SuharjonoUniversity of Brawijaya1
Muhammad Darwin PrenggonoLambung Mangkurat University1
Ratih Pratiwi SariUniversitas Airlangga1
Aditya Maulana Perdana PutraLambung Mangkurat University1
Andi Bulqiah NurState University of Makassar1
Moch YusufUniversitas Airlangga1
YulistianiUniversitas Airlangga1
Wulida Nuril FajriyahState University of Makassar1
Zam Zami JauhariUniversitas Airlangga1
Diyah WahyuniUniversitas Airlangga1
Ramadi Satryo WicaksonoAffiliation unknown1
Abdul Kadir JaelaniAffiliation unknown1
Vini Siane TanaemUniversitas Airlangga1
Dwi Aris Agung NugrahaningsihUniversitas Gadjah Mada1
Ahmad Hamim SadewaUniversitas Gadjah Mada1
Ellsya Angeline RawarUniversitas Kristen Immanuel1
Ani KristiyaniUniversitas Kristen Immanuel1
Christine PatramurtiSanata Dharma University1
Endang Dewi MasithahUniversitas Airlangga1
Aondohemba Samuel NegeJoseph Sarwuan Tarka University Makurdi1
Cantika Suci Adlina LasandaraUniversitas Airlangga1
Samirah SamirahUniversitas Airlangga1
Aniek Setiya BudiatinUniversitas Airlangga1
Anak Agung Ngurah Putra Riana PrasetyaUniversitas Airlangga1
Bayu Dharma ShantiAffiliation unknown1
Dewi Perwito SariUniversitas Airlangga1
Yulistiani YulistianiUniversitas Airlangga1
Mida PurwiningtyasUniversitas Airlangga1
Bayu Dharma SantiAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">EFFECT OF HYDROXYETHYL STARCH 200/0.5 ON VON WILLEBRAND FACTOR SERUM LEVEL AND ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)</dc:title><dc:creator>Sarah Puspita Atmaja</dc:creator><dc:creator>Junaidi Khotib</dc:creator><dc:creator>Eddy Rahardjo</dc:creator><dc:creator>Dewi Wara Shinta</dc:creator><dc:creator>Mahardian Rahmadi</dc:creator><dc:creator>Budi Suprapti</dc:creator><dc:subject>hydroxyethyl starch 200/0.5</dc:subject><dc:subject>von Willebrand factor</dc:subject><dc:subject>activated partial thromboplastin time</dc:subject><dc:subject>colloid infusion</dc:subject><dc:subject>intravascular volume expansion</dc:subject><dc:subject>perioperative fluid management</dc:subject><dc:subject>hemostasis</dc:subject><dc:subject>elective surgery</dc:subject><dc:subject>coagulation</dc:subject><dc:description xml:lang="en">Hydroxyethyl starch (HES) is a colloid administered frequently for intravascular volume expansion during perioperative period. Impairment of haemostasis have been reported during HES administration, but the volume of solution administered was usually higher than 20 ml.kg-1. The objective of this study was to evaluate the effect of Hydroxyethyl starch 200/0.5 dose less than 20 ml.kg-1 on von Willebrand factor serum level and activated partial thromboplastin time. A prospective, observational study was conducted to evaluate von Willebrand factor and activated partial thromboplastin time of patients receiving Hydroxyethyl starch 200/0.5. Inclusion criteria were patients undergoing elective surgery who were going to receive Hydroxyethyl starch 200/0.5 intraoperatively. Fourty six patients were divided into patients receiving crystalloid only group (n=23 patients) and hydroxyethyl starch (n=23 patients). Coagulation variables were assesed 30 minute after insicion and 60 minute after infusion of crystalloid or colloid. Measurement of von Willebrand within each group after crystalloid or HES 200 infusion showed significant decrease, from (mean±SE) 97.688±15.219 ng/ml to 31.611±10.058 ng/ml (p&lt; 0.001) in crystalloid group and 92.884±15.208 ng/ml to 27.378±6.399 ng/ml (p&lt;0.001) in HES 200 group. Activated partial thromboplastin time change was statistically significant (mean±SE) 31.27±1.39 to 35.61±1.62 in HES group only (p=0.007), but this change was not clinically significant. In conclusion, there was neither significant difference in von Willebrand serum level nor in activated partial thromboplastin time between the two groups. There was no coagulation influence with clinically significant effect in the use of HES 20 ml/kg BW in patients undergoing elective surgery.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2016-11-15</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v51i4.2848</dc:identifier><dc:identifier>10.20473/fmi.v51i4.2848</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 51 No 4 (2016); 221-221</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/2848/2063</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>